论文部分内容阅读
冷冻治疗肝癌113例,其中原发性肝癌(PLC)107例、转移性肝癌(SLC)6例。用盘形冷冻头治疗位于肝浅表肿瘤,单针或多针冷冻头插入瘤体内治疗位于肝深部肿瘤术中B超监测冷冻范围。全组无手术死亡。107例PLC患者冷冻后5年和10年生存率分别为22.0％、8.2％,其中32例PLC≤5cm患者则分别为48.8％、17.1％。6例SLC患者冷冻后平均生存25.2个月(2～90个月)。本文提示:冷冻对手术不能切除肝癌是一种安全、有一定疗效的局部治疗方法。
There were 113 cases of liver cancer cryotherapy, including 107 cases of primary liver cancer (PLC) and 6 cases of metastatic liver cancer (SLC). Treatment of superficial tumors in the liver with disc-shaped frozen heads, single-needle or multi-needle cryosurgery into the tumor in the treatment of deep tumors in the liver during surgery B-monitoring the scope of frozen. There was no operative death in the entire group. The 5-year and 10-year survival rates of 107 PLC patients after freezing were 22.0% and 8.2%, respectively, of which 32 patients with PLC≤5cm were 48.8% and 17.1%, respectively. Six patients with SLC had an average survival of 25.2 months (2 to 90 months) after freezing. This article suggests that cryosurgery is not a safe, localized treatment with certain curative effects.